Onglyza Trademark Details

Onglyza was registered on Tuesday, December 8, 2009 and is currently owned by Astrazeneca Ab under the registration number 3723838 . This mark is alive with a status of Section 8 & 15-Accepted and Acknowledged. The last case file activity for this mark occured 8 years ago on Wednesday, August 12, 2015, according to the United State Patent & Trademark Office
Word Mark Onglyza
Status Alive Registered 702 — Section 8 & 15-Accepted and Acknowledged
Serial Number 78791308
Registration Number 3723838
Status Date Wednesday, August 12, 2015
Filing Date Wednesday, August 12, 2015
Registration Date Tuesday, December 8, 2009
Attorney Marc Stanislawczyk

Correspondent

Marc Stanislawczyk
AstraZeneca Pharmaceuticals LLP
FOP3-022
1800 Concord Pike
Wilmington DE 19850-5437

Case File Statements

Goods & Services Pharmaceutical preparations for human use for the treatment and prevention of diabetes

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Thursday, January 19, 2006
First Use Anywhere Friday, July 31, 2009
First Use In Commerce Friday, July 31, 2009
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.